Rapport Therapeutics, Inc. Shares Outstanding (Cover Page)
Rapport Therapeutics, Inc. (RAPP) had Shares Outstanding (Cover Page) of 47.98 million shares as of 2026-08-03, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-05
- 2026-08-03: Entity Common Stock, Shares Outstanding 47.98M shares.
- 2026-05-04: Entity Common Stock, Shares Outstanding 47.83M shares.
- 2026-03-02: Entity Common Stock, Shares Outstanding 47.79M shares.
- 2025-11-04: Entity Common Stock, Shares Outstanding 47.66M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-03 | 47.98M shares 10-Q · filed 2026-08-05 |
| 2026-05-04 | 47.83M shares 10-Q · filed 2026-05-07 |
| 2026-03-02 | 47.79M shares 10-K · filed 2026-03-10 |
| 2025-11-04 | 47.66M shares 10-Q · filed 2025-11-06 |
| 2025-08-04 | 36.50M shares 10-Q · filed 2025-08-07 |
| 2025-05-06 | 36.50M shares 10-Q · filed 2025-05-08 |
| 2025-03-01 | 36.50M shares 10-K · filed 2025-03-11 |
| 2024-11-06 | 36.58M shares 10-Q · filed 2024-11-07 |
| 2024-08-08 | 36.58M shares 10-Q · filed 2024-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |